Vac-CRT/E7 and Vac-CRT

Case ID:

C10933

C10933: Vac-CRT/E7 and Vac-CRT
Technical Details:
The Vac-CRT/E7 vaccine can be employed to deliver chimeric CRT/E7 gene into the host cells in order to generate potent E7-specific CD8+ T cell immune responses and antitumor effects against E7- expressing tumors.
Looking for Partners:
Cervical cancer vaccine
Publications:
1. Hsieh CJ, Kim TW, Hung CF, Juang J, Moniz M, Boyd DA, He L, Chen PJ, Chen CH, Wu TC. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. Vaccine. 2004 Sep 28;22(29-30):3993-4001

Direct Link:

https://jhu.technologypublisher.com/technology/16790

Inventors:

Category(s):

Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology > Cervical Cancer, Clinical and Disease Specializations > Women's Health, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Oncology,

Get custom alerts for techs in these categories/from these inventors:

Subscribe for JHTV Updates

For Information, Contact:

Sahil Aggarwal

sahil.aggarwal@jhu.edu

410-614-0300

Save This Technology:

Bookmark this page

Download as PDF